Diabetes drug slows early-onset puberty in girls

User rating: not rated yet

In young girls at risk of early puberty and insulin resistance, the diabetes drug metformin delayed the onset of menstruation and decreased the development of insulin resistance, a risk factor for type 2 diabetes, according to a new study. The results were presented Monday, June 16, at The Endocrine Society's 90th Annual Meeting in San Francisco.


Full story »
All News summaries from Medicine & Health news
All News summaries for June 16, 2008

Researchers provide solution to world's worst mass poisoning case

2 hours ago | User rating: not rated yet
A solution to the world's worst case of ongoing mass poisoning, linked to rising cancer rates in Southern Asia, has been developed by researchers from Queen's University Belfast.

Common treatment to delay labor decreases preterm infants' risk for cerebral palsy

2 hours ago | User rating: not rated yet
Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, ...

Class of diabetes drugs carries significant cardiovascular risks

3 hours ago | User rating: not rated yet
A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members.

Tiny 3-D ultrasound probe guides catheter procedures

3 hours ago | User rating: not rated yet
An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance.

Variation of normal protein could be key to resistance to common cancer drug

3 hours ago | User rating: not rated yet
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. ...
Goto Archive PhysOrg Forum Goto Archive Video Goto Archive Editorials Goto Archive Free Magazines Goto Archive Newsletter

News Archive